Valuation Amarin Corporation plc

Stocks

Real-time Estimate Cboe BZX Other stock markets 18:13:44 10/07/2026 +04			5-day change	1st Jan Change
14.78 ^USD	-2.25%		-4.32%	+7.85%

07-02	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	MT
07-01	Amarin Corporation plc Reaffirms the Proven Guideline-Recommended Role of Vascepa (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,333	488.6	355.2	199.5	290.2	317.1	-	-
Change	-	-63.35%	-27.3%	-43.84%	45.45%	9.27%	-	-
Enterprise Value (EV) ¹	1,114	270.4	156	78.46	155.5	143.2	129.6	125.1
Change	-	-75.72%	-42.33%	-49.69%	98.19%	-7.92%	-9.51%	-3.48%
P/E	169x	-4.65x	-5.8x	-2.43x	-155x	-504x	-756x	-378x
PBR	2x	0.82x	0.64x	0.41x	-	-	-	-
PEG	-	0x	0.1x	-0.1x	1.6x	7.6x	22.7x	-4x
Capitalization / Revenue	2.29x	1.32x	1.16x	0.87x	1.36x	1.78x	2x	2.26x
EV / Revenue	1.91x	0.73x	0.51x	0.34x	0.73x	0.81x	0.82x	0.89x
EV / EBITDA	44.9x	-5.69x	-2.31x	-0.86x	-3.1x	-5.6x	-6.29x	-4.43x
EV / EBIT	46x	-3.64x	-2.31x	-0.85x	-3.1x	-5.6x	-6.29x	-4.43x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.4	-5.2	-3	-4	-0.09	-0.03	-0.02	-0.04
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	583.2	369.2	306.9	228.6	213.6	177.8	158.8	140.2
EBITDA ¹	24.81	-47.5	-67.43	-91.7	-50.17	-25.57	-20.61	-28.21
EBIT ¹	24.22	-74.26	-67.59	-91.8	-50.17	-25.58	-20.61	-28.21
Net income ¹	7.729	-105.8	-59.11	-82.18	-38.8	-12.75	-9.038	-16.28
Net Debt ¹	-219.5	-218.2	-199.3	-121	-134.7	-173.9	-187.5	-192
Reference price ²	67.40	24.20	17.40	9.70	13.96	15.12	15.12	15.12
Nbr of stocks (in thousands)	19,781	20,191	20,415	20,567	20,793	20,969	-	-
Announcement Date	01/03/22	01/03/23	29/02/24	12/03/25	25/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AMARIN CORPORATION PLC	-504x	0.81x	-5.6x	-	317M
ARGENX SE	34.14x	8.68x	26.92x	0.05%	56.98B
WUXI APPTEC CO., LTD.	20.2x	6.2x	13.51x	1.5%	53.58B
INSMED INCORPORATED	-44.73x	14.86x	-43.31x	-.--%	25.63B
BIONTECH SE	-18.5x	4.48x	-7.85x	-.--%	23.51B
WUXI BIOLOGICS (CAYMAN) INC.	24.36x	4.79x	12.56x	-.--%	19.43B
GENMAB A/S	25.29x	4.92x	16.02x	-.--%	18.12B
PHARMAESSENTIA CORPORATION	49.34x	20.07x	51.69x	0.11%	16.46B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-495.91x	34.06x	-3797.57x	-.--%	14.13B
EXELIXIS, INC.	17.96x	5.22x	12.19x	-.--%	14.35B
Average	-89.19x	10.41x	-372.14x	0.18%	24.25B
Weighted average by Cap.	-15.35x	9.82x	-210.92x	0.35%